NEOGENOMICS INC
A cancer diagnostics company offering genetic testing and pharmaceutical services.
NEO | US
Overview
Corporate Details
- ISIN(s):
- US64049M2098
- LEI:
- Country:
- United States of America
- Address:
- 9490 NEOGENOMICS WAY, 33912 FORT MYERS
- Website:
- https://neogenomics.com/
- Industry:
- Other human health activities
Description
NeoGenomics, Inc. is a cancer diagnostics company specializing in genetics testing, oncology data solutions, and pharmaceutical services. It provides a comprehensive menu of over 500 tests for both solid tumors and hematologic cancers, supporting oncologists and healthcare providers with diagnostic, prognostic, and predictive insights for personalized patient care. The company's testing modalities include immunohistochemistry (IHC), flow cytometry, fluorescence in situ hybridization (FISH), next-generation sequencing (NGS), and comprehensive genomic profiling (CGP). Additionally, NeoGenomics partners with biopharmaceutical companies to support drug development, clinical trials, and biomarker discovery, leveraging its extensive multi-modal dataset to offer advanced oncology data solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all NEOGENOMICS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NEOGENOMICS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NEOGENOMICS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
